As Medicare's Quality Improvement Organization (QIO) for Oregon, Acumentra Health is convening and assisting local community teams participating in the national Patient Safety and Clinical Pharmacy Services Collaborative (also called Patient Safety Pharmacy Collaborative, or PSPC). The goal of QIO-supported PSPC participation is to engage clinical pharmacy services, medical practices, health plans, and other stakeholders in activities to reduce adverse drug events.
The Oregon PSPC project is part of the national PSPC, drawing on the knowledge of national and local leaders in drug safety. Oregon projects focus on improving medication safety for high-need patients managing multiple complex chronic conditions. Interventions incorporate evidence-based practices as well as best practices from the national PSPC. In addition to face-to-face and virtual meetings, support for the teams will include an array of collaboration and learning tools via the Healthcare Communities knowledge-sharing portal.
Between August 2011 and August 2014, Acumentra Health will charter and work with 5 community teams, synchronizing activities with the national PSPC. We are currently working with 3 teams, all focused on use of antipsychotic medications.
Oregon PSPC teams benefit from Acumentra Health's experience leading the Prescription Drug Safety Project from 2008 through 2011. The project supported Oregon Medicare Advantage plans in collaborative work to measure the incidence of potentially inappropriate medications and potential drug–drug interactions and share data with providers to address these risks.
Last updated April 9, 2013